ICA-2001

N/A

Report date: 2023/09/06 17:59:21

Base Information

Drug NameICA-2001
Drug Alias NameICA-2001ICA2001
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Aika Liyuan Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Aika Liyuan Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A